← Back to Patent Explorer
US5041644A Expired / Lapsed US ⏱️ 0.0 years remaining

Peptide derivatives of β-chloro-L(Z)-dehydro-glutamic acid

Assignee: Merck and Co Inc
•
Filing: 1988-06-27
•
Granted: 1991-08-20
•
Expires: 2008-06-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New peptide derivatives β-chloro-L-(Z)-dehydroglutamic acid are described which display antibacterial activity.

Inventors

  • 👤 Yoshiharu Morita
  • 👤 Ryoichi Ando
  • 👤 Junko Takashima
  • 👤 Louis Chaiet

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 09:26
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/02; C07K5/0212; C07C; C07C237/00; C07C237/02; C07C237/04; C07C237/12; C07K5/04; C07K5/06; C07K5/06191; C07K5/08; C07K5/0827; C07K7/00; C07K7/02

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 130 words
A compound represented by the general formula (I) ##STR6## wherein X is a hydrogen atom or an amino acid or oligopeptide residue obtained by removing, from an amino acid or oligopeptide, the hydroxyl group of the terminal carboxyl group; Y and Z are each a hydroxyl group which may optionally be protected, or an amino acid or oligopeptide residue obtained by removing, from an amino acid or oligopeptide, the hydrogen atom of the terminal amino group; when Y and Z are each said amino acid or oligopeptide residue, each terminal carboxyl group of the respective residues may be protected by a same or different protecting group; and a case is excluded where X is a hydrogen atom and Y and Z are each a hydroxyl group which may be protected.
Claim 2
Dependent Claim 130 words
A compound represented by the general formula (I) ##STR6## wherein X is a hydrogen atom or an amino acid or oligopeptide residue obtained by removing, from an amino acid or oligopeptide, the hydroxyl group of the terminal carboxyl group; Y and Z are each a hydroxyl group which may optionally be protected, or an amino acid or oligopeptide residue obtained by removing, from an amino acid or oligopeptide, the hydrogen atom of the terminal amino group; when Y and Z are each said amino acid or oligopeptide residue, each terminal carboxyl group of the respective residues may be protected by a same or different protecting group; and a case is excluded where X is a hydrogen atom and Y and Z are each a hydroxyl group which may be protected.
Claim 3
Dependent Claim 167 words
A compound according to claim 1, wherein X is a hydrogen atom; a residue of amino acid of glycine, alanine, valine, norvaline, leucine, isoleucine, serine, threonine, phenylalanine, tyrosine, tryptophan, histidine, aspartic acid, asparagine, glutamic acid, glutamine, lysine, arginine, cysteine or methionine, or an oligopeptide residue constituted of 2 to 10 of the above mentioned amino acids, and Y and Z are respectively an OH group optionally having a protecting group of C 1 -C 10 straight chain or branched chain alkyl group optionally having a substituent, or aryl group optionally having a substituent; a residue of amino acid of glycine, alanine, valine, norvaline, leucine, isoleucine, serine, threonine, phenylalanine, tyrosine, tryptophan, histidine, aspartic acid, asparagine, glutamic acid, glutamine, lysine, arginine, cysteine, methionine or proline, optionally having a protecting group selected from C 1 -C 10 straight chain or branched chain alkyl group optionally having a substituent and aryl group optionally having a substituent, or an oligopeptide residue constituted of 2 to 10 of the above mentioned amino acids.
Claim 4
Dependent Claim 128 words
A compound according to claim 1, wherein X is hydrogen atom; a residue of amino acid of glycine, alanine, valine, norvaline, leucine, isoleucine, serine, cysteine or methionine, or an oligopeptide residue constituted of 2 to 5 of the above mentioned amino acids, and Y and Z are respectively an OH group optionally having a protecting group selected from C 1 -C 10 alkyl group, methoxymethyl, acetoxymethyl, pivaloyloxymethyl, benzyl, p-nitrobenzyl, p-methoxybenzyl, phthalidyl, phenyl and indanyl; a residue of amino acid of glycine, alanine, valine, norvaline, leucine, isoleucine, serine, cysteine or methionine, optionally having a protecting group selected from C 1 -C 10 alkyl group, methoxymethyl, acetoxymethyl, pivaloyloxymethyl, benzyl, p-nitrobenzyl, p-methoxybenzyl, phthalidyl, phenyl and indanyl, or an oligopeptide residue constituted of 2 to 5 of the above mentioned amino acids.
Claim 5
Dependent Claim 125 words
A compound according to claim 1, wherein X is a hydrogen atom; a residue of amino acid of glycine, alanine, valine, norvaline, leucine, isoleucine, serine, cysteine or methionine, or an oligopeptide residue constituted of 2 to 5 of the above mentioned amino acids, and Y and Z are respectively an OH group optionally having a protecting group selected from methyl, ethyl, propyl, tert-butyl, methoxymethyl, acetoxymethyl, pivaloyloxymethyl, benzyl, p-nitrobenzyl, p-methoxybenzyl, phthalidyl, phenyl and indanyl; a residue of amino acid of glycine, alanine, valine, norvaline, leucine, isoleucine, serine, cysteine or methionine, optionally having a protecting group selected from methyl, ethyl, propyl, tert-butyl, methoxymethyl, acetoxymethyl, pivaloyloxymethyl, benzyl, p-nitrobenzyl, p-methoxybenzyl, phthalidyl, phenyl and indanyl, or an oligopeptide residue constituted of 2 to 5 of the above mentioned amino acids.
Claim 6
Dependent Claim 87 words
A compound according to claim 1 wherein X is a hydrogen atom; a residue of amino acid of L-alanine or L-norvaline, or an oligopeptide residue constituted of 2 of the above mentioned amino acids, and Y and Z are respectively an OH group optionally having a substituent of C 1 -C 5 alkyl group; a residue of amino acid of L-alanine or L-norvaline, optionally having a substituent of C 1 -C 5 alkyl group, or an oligopeptide residue constituted of 2 of the above mentioned amino acids.
Claim 7
Dependent Claim 89 words
A compound according to claim 1, wherein X is a hydrogen atom; a residue of amino acid of L-alanine or L-norvaline, or an oligopeptide residue constituted of 2 of the above mentioned amino acids, Y is an OH group optionally having a substituent of C 1 -C 3 alkyl group, and Z is an OH group; a residue of amino acid of L-alanine or L-norvaline, optionally having a substituent of C 1 -C 3 alkyl group, or an oligopeptide residue constituted of 2 of the above mentioned amino acids.
Claim 8
Dependent Claim 23 words
The compound according to claim 1 selected from: L-alanyl-β-chloro-L-(Z)-dehydroglutamic acid; L-norvalyl-β-chloro-L-(Z)-dehydroglutamic acid; L-alanyl-L-alanyl-β-chloro-L-(Z)-dehydroglutamic acid; methyl ester of β-chloro-L-(Z)-dehydroglutamyl-L-norvaline; and methyl ester of β-chloro-ε-(1-methoxycarbonylbutyl)-L-(Z)-dehydroglutaminyl-L-norvaline.

References Cited (Backward Citations)

US4147780A Cited
US4160452A Cited
US4256108A Cited
US4265874A Cited
US4539208A Cited
US4374131A Cited
US4416833A Cited
EP0091594A1 Cited
EP0161546A1 Cited
EP0209848A2 Cited
EP0210545A2 Cited
US4715994A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-08-19 1995-02-18 1995-08-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-08-19 1999-02-18 1999-08-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-08-19 2003-02-18 2003-08-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag